PATENT CLAIM ANALYSIS

Application Number: 16000283
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-05
Patent Classification: ["548", "248000"]

Abstract:
A method for treating a lysophosphatidic acid-dependent disease or condition in a subject in need thereof is provided. The method includes administering to the subject a therapeutically effective amount of a heterocyclic compound. The heterocyclic compound is a lysophosphatidic acid receptor ligand. Lysophosphatidic acid-dependent diseases and conditions include diseases involving fibrosis, such as fibrosis of the heart, kidney, liver and lung, and scleroderma; inflammatory diseases such as diabetic nephropathy and inflammatory bowel disease; ocular diseases such as diseases involving retinal degeneration; nerve diseases such as pruritus and pain.

Claim (Index 33):
The method according to  claim 27 , wherein the lysophosphatidic acid-dependent disease or condition is fibrosis, liver disease, acute hepatitis, chronic hepatitis, liver fibrosis, liver cirrhosis, portal hypertension, regenerative failure, nonalcoholic steatohepatitis (NASH), liver hypofunction, hepatic blood flow disorder, cell proliferative disease, cancer, inflammatory disease, psoriasis, nephropathy, diabetic nephropathy, pneumonia, gastrointestinal tract disease, irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), abnormal pancreatic secretion, renal disease, urinary tract-associated disease, benign prostatic hyperplasia, symptoms associated with neuropathic bladder disease, spinal cord tumor, hernia of intervertebral disk, spinal canal stenosis, symptoms derived from diabetes, lower urinary tract disease, inflammatory disease of lower urinary tract, dysuria, frequent urination, pancreas disease, abnormal angiogenesis-associated disease, arterial obstruction, scleroderma, brain-associated disease, cerebral infarction, cerebral hemorrhage, nervous system diseases, neuropathic pain, peripheral neuropathy, pruritus, ocular disease, age-related macular degeneration (AMD), diabetic retinopathy, uveitis, proliferative vitreo-retinopathy (PVR), cicatricial pemphigoid, or glaucoma filtration surgery scarring.

Metadata:
- Claim Count in Document: 65.0
- Percentile: 94.0
- Lexical Diversity: 1.73684
- Patent Class: 548.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14776954', '13388502', '13992053', '12793440', '13246746']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7675694099542009
- 35 USC 102 Novelty (BERT): 0.5775900325051431
- Combined Prediction Score: 0.7485714722092951
- Mean Citation Score: 398.165098
- Max Citation Score: 573.10284
- Similarity Product: 341.3643782705355

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test